Abstract

Rotavirus vaccine: a promise for the future.

Highlights

  • Studies have shown that rotavirus-associated disease occurs round the year in tropical climates with no consistent seasonal variation, there may be more peaks in the dry, cool months, or winter months [11]

  • Safe and effective rotavirus vaccines are needed to reduce the enormous public-health burden associated with illness due to rotavirus, especially in developing countries [14]

  • The large global burden of healthcare due to rotavirus-associated disease in both developed and developing countries prompted the development of rotavirus vaccines

Read more

Summary

Introduction

Studies have shown that rotavirus-associated disease occurs round the year in tropical climates with no consistent seasonal variation, there may be more peaks in the dry, cool months, or winter months [11]. Safe and effective rotavirus vaccines are needed to reduce the enormous public-health burden associated with illness due to rotavirus, especially in developing countries [14]. The large global burden of healthcare due to rotavirus-associated disease in both developed and developing countries prompted the development of rotavirus vaccines. The vaccine had an efficacy of 85-98% against severe rotavirus-associated disease requiring hospitalization and reduced all-cause hospitalizations by 42-59%, preventing most hospitalizations for rotavirus [17,18].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call